chevron_leftBack
As of 15 June 2026, Zhejiang Int'l Group Co.,Ltd. has a market cap of $885.29M USD, ranking #11417 globally and #3301 in China.
It ranks #1032 in the Healthcare sector, and #387 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$885.29MUSD
6.0B CNY
Enterprise Value
$1.39BUSD
9.4B CNY
Revenue (TTM)
$4.99BUSD
33.84B CNY
EBITDA (TTM)
$152.85MUSD
1.03B CNY
Net Income (TTM)
$70.93MUSD
480.59M CNY
EBITDA Margin
3.1%
Profit Margin
1.4%
PE Ratio
12.0
PS Ratio
0.2
PB Ratio
1.0
EV/EBITDA
8.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yang Wang
open_in_new
Employees
3,072
Founded
1950
Website
intmedic.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.2% | -5% | -2.1% | -17% | -4.5% | 3.6% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
000411
浙江英特集团股份有限公司
ISIN: CNE0000008D9
Shares Out.:
Shares Outstanding:
564.659M1
Shares Float:
167.382M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
10.60 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zhejiang Int'l Group Co.,Ltd.
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. It offers chemical drugs, biological products, and Chinese patent medicine. The company was founded in 1950 and is based in Hangzhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
6K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
6K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
3K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
2K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
2K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
86K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
62K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
41K%
|
97.4
|
|
SIX: RO
|
$321.52B
36K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
33K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
31K%
218.9B CHF
|
20.5
|
chevron_leftBack